The diagnostic models established with the serum fluorescence parameters, particularly combined with AFP, hepatic function tests and blood cell analyses, showed robust diagnostic performances for PHC (including ICC), especially for AFP-negative, BCLC stage A and small PHCs. This evidence concerns the gene AFP and intrahepatic cholangiocarcinoma.